PetIQ, Inc. Enters Into Definitive Agreement to Acquire Perrigo Animal Health
May 08, 2019 16:05 ET
|
PetIQ, Inc.
Diversifies and Expands Branded Pet Health and Wellness Product Offerings to Create an Animal Health Company with Approximately $605 Million in Pro Forma 2018 Net Sales Combines PetIQ’s and Perrigo...
PetIQ, Inc. to Report First Quarter 2019 Results on Wednesday, May 8th
April 23, 2019 08:05 ET
|
PetIQ, Inc.
EAGLE, Idaho, April 23, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the...
PetIQ, Inc. Reports Record Fourth Quarter and Full Year 2018 Financial Results
March 11, 2019 16:05 ET
|
PetIQ, Inc.
Fourth Quarter 2018 Net Sales Increased 114% Year-Over-Year to $111.0 Million Full Year 2018 Net Sales of $528.6 Million Provides Full Year 2019 Outlook EAGLE, Idaho, March 11, 2019 (GLOBE...
PetIQ, Inc. Announces Appointment of R. Michael Herrman as General Counsel
February 25, 2019 08:00 ET
|
PetIQ, Inc.
EAGLE, Idaho, Feb. 25, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of R. Michael...
PetIQ, Inc. to Report Fourth Quarter and Full Year 2018 Results on Monday, March 11th
February 20, 2019 08:00 ET
|
PetIQ, Inc.
EAGLE, Idaho, Feb. 20, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the...
PetIQ, Inc. to Participate in the Bank of America Merrill Lynch Animal Health Summit
February 19, 2019 08:00 ET
|
PetIQ, Inc.
EAGLE, Idaho, Feb. 19, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that the executive management...
PetIQ, Inc. Announces Amicable Legal Resolution
January 22, 2019 08:00 ET
|
PetIQ, Inc.
PetIQ to Continue Offering Customers Its Advecta3® and PetLock® MAX Formulations EAGLE, Idaho, Jan. 22, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading...
PetIQ, Inc. to Participate in the 2019 ICR Conference
January 08, 2019 08:00 ET
|
PetIQ, Inc.
EAGLE, Idaho, Jan. 08, 2019 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that the executive management...
PetIQ, Inc. Reports Third Quarter 2018 Financial Results
November 13, 2018 16:05 ET
|
PetIQ, Inc.
Third Quarter Net Sales Increase 117% Year-Over-Year to $131.4 Million Raises Full Year 2018 Net Sales Outlook to Approximately $515 Million EAGLE, Idaho, Nov. 13, 2018 (GLOBE NEWSWIRE) -- PetIQ,...
PetIQ, Inc. to Report Third Quarter 2018 Results on Tuesday, November 13th
October 29, 2018 08:00 ET
|
PetIQ, Inc.
EAGLE, Idaho, Oct. 29, 2018 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the...